• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global heparin market is expected to grow at a CAGR of around 5% during 2019-2024. Heparin, denoted by the chemical formula C12H19NO20S3, is a sulfur-containing polysaccharide that acts as an anticoagulant or a blood thinner. It prevents the formation of blood clots inside blood vessels and is used for the treatment of heart conditions and unstable angina. It is also used in post-surgeries as well as during dialysis and blood transfusion. Heparin is usually injected directly into the muscle or the veins to break up clots and maintain smooth fluidity of the blood. Some common side-effects of using heparin include easy bruising and itchy skin with redness.

Heparin Market

The rising prevalence of various medical ailments such as deep vein thrombosis (DVT) and pulmonary embolism (PE) is one of the key factors driving the global market. Also, heparin has been proven to be an extremely effective drug for venous thromboembolism and cardiovascular disorders (CVDs), which is contributing significantly to its market growth. Furthermore, biopharmaceutical companies are developing innovative medicines to enhance the therapeutic potential of heparin and reduce its side-effects. Availability of synthetic and semi-synthetic heparin mimetics that assist in treating various cancers, coagulation and inflammatory diseases is significantly increasing the adoption of the product. The market is further driven by the various advancements in the field of carbohydrate synthesis, which include building block preparation, coupling reactions and the development of convergent strategies. Moreover, increasing government funding toward improving healthcare facilities and extensive research and development (R&D) activities to develop heparin with ultra-low molecular weight for utilization in chemotherapy are also creating a positive outlook for the market.

IMARC Group’s latest report provides a deep insight into the global heparin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the heparin market in any manner.

Report Coverage:

  • Historical, Current and Future Market Trends
     
  • Market Breakup by Product:
    • Unfractionated Heparin 
    • Low Molecular Weight Heparin (LMWH)
    • Ultra-low Molecular Weight Heparin (ULMWH)
       
  • Market Breakup by Source:
    • Bovine
    • Porcine
       
  • Market Breakup by Mode of Administration:
    • Oral
    • Parenteral
       
  • Market Breakup by Application:
    • Atrial Fibrillation & Heart Attack
    • Stroke
    • Deep Vein Thrombosis (DVT)
    • Pulmonary Embolism (PE)
    • Others
       
  • Market Breakup by End-User:
    • Hospitals
    • Clinics
    • Homecare Settings
    • Ambulatory Surgical Centers
    • Others
       
  • Market Breakup by Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Online Stores
    • Others
       
  • Market Breakup by Region:
    • Europe
    • North America
    • Asia Pacific
    • Middle East and Africa
    • Latin America
       

Competitive Landscape:

The report has also analyzed the competitive landscape of the market with some of the key players being GlaxoSmithKline, Hepalink, Pfizer, LeoPharma, Sanofi, Dr. Reddy’s Laboratories, Teva Pharmaceutical Industries, Aspen, LEO Pharma, Baxter, Changshan Pharm, Sandoz, Opocrin, Deebio, Tiandong, etc.

Key Questions Answered in This Report:

  • How has the global heparin market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global heparin industry?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the source?
  • What is the breakup of the market based on the mode of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end-user?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the global heparin industry?
  • What are the key driving factors and challenges in the global heparin industry?
  • What is the structure of the global heparin industry and who are the key players?
  • What is the degree of competition in the global heparin industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Heparin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Product
    5.4    Market Breakup by Source
    5.5    Market Breakup by Mode of Administration
    5.6    Market Breakup by Application
    5.7    Market Breakup by End-User
    5.8    Market Breakup by Distribution Channel
    5.9    Market Breakup by Region
    5.10    Market Forecast
6    Market Breakup by Product
    6.1    Unfractionated Heparin
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Low Molecular Weight Heparin (LMWH)
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Ultra-Low Molecular Weight Heparin (ULMWH)
        6.3.1    Market Trends
        6.3.2    Market Forecast
7    Market Breakup by Source
    7.1    Bovine
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Porcine
        7.2.1    Market Trends
        7.2.2    Market Forecast
8    Market Breakup by Mode of Administration
    8.1    Oral
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Parenteral
        8.2.1    Market Trends
        8.2.2    Market Forecast
9    Market Breakup by Application
    9.1    Atrial Fibrillation & Heart Attack
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Stroke
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Deep Vein Thrombosis (DVT)
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Pulmonary Embolism (PE)
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Others 
        9.5.1    Market Trends
        9.5.2    Market Forecast
10    Market Breakup by End-User
    10.1    Hospitals
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Clinics
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Homecare Settings
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Ambulatory Surgical Centers
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Others 
        10.5.1    Market Trends
        10.5.2    Market Forecast
11    Market Breakup by Distribution Channel
    11.1    Hospital Pharmacies
        11.1.1    Market Trends
        11.1.2    Market Forecast
    11.2    Retail Pharmacies
        11.2.1    Market Trends
        11.2.2    Market Forecast
    11.3    Drug Stores
        11.3.1    Market Trends
        11.3.2    Market Forecast
    11.4    Online Stores
        11.4.1    Market Trends
        11.4.2    Market Forecast
    11.5    Others
        11.5.1    Market Trends
        11.5.2    Market Forecast
12    Market Breakup by Region
    12.1    Europe
        12.1.1    Market Trends
        12.1.2    Market Forecast
    12.2    North America
        12.2.1    Market Trends
        12.2.2    Market Forecast
    12.3    Asia Pacific
        12.3.1    Market Trends
        12.3.2    Market Forecast
    12.4    Middle East and Africa
        12.4.1    Market Trends
        12.4.2    Market Forecast
    12.5    Latin America
        12.5.1    Market Trends
        12.5.2    Market Forecast
13    SWOT Analysis
    13.1    Overview
    13.2    Strengths
    13.3    Weaknesses
    13.4    Opportunities
    13.5    Threats
14    Value Chain Analysis
15    Porter’s Five Forces Analysis

    15.1    Overview
    15.2    Bargaining Power of Buyers
    15.3    Bargaining Power of Suppliers
    15.4    Degree of Competition
    15.5    Threat of New Entrants
    15.6    Threat of Substitutes
16    Price Analysis
17    Competitive Landscape

    17.1    Market Structure
    17.2    Key Players
    17.3    Profiles of Key Players
        17.3.1    GlaxoSmithKline
        17.3.2    Hepalink 
        17.3.3    Pfizer
        17.3.4    LeoPharma
        17.3.5    Sanofi
        17.3.6    Dr. Reddy’s Laboratories
        17.3.7    Teva Pharmaceutical Industries
        17.3.8    Aspen
        17.3.9    LEO Pharma
        17.3.10     Baxter
        17.3.11     Changshan Pharm
        17.3.12     Sandoz
        17.3.13     Opocrin
        17.3.14     Deebio
        17.3.15     Tiandong

List of Figures

Figure 1: Global: Heparin Market: Major Drivers and Challenges
Figure 2: Global: Heparin Market: Sales Value (in Billion US$), 2013-2018
Figure 3: Global: Heparin Market: Breakup by Product (in %), 2018
Figure 4: Global: Heparin Market: Breakup by Source (in %), 2018
Figure 5: Global: Heparin Market: Breakup by Mode of Administration (in %), 2018
Figure 6: Global: Heparin Market: Breakup by Application (in %), 2018
Figure 7: Global: Heparin Market: Breakup by End-User (in %), 2018
Figure 8: Global: Heparin Market: Breakup by Distribution Channel (in %), 2018
Figure 9: Global: Heparin Market: Breakup by Region (in %), 2018
Figure 10: Global: Heparin Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 11: Global: Heparin Industry: SWOT Analysis
Figure 12: Global: Heparin Industry: Value Chain Analysis
Figure 13: Global: Heparin Industry: Porter’s Five Forces Analysis
Figure 14: Global: Heparin (Unfractionated Heparin) Market: Sales Value (in Million US$), 2013 & 2018
Figure 15: Global: Heparin (Unfractionated Heparin) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: Heparin (Low Molecular Weight Heparin) Market: Sales Value (in Million US$), 2013 & 2018
Figure 17: Global: Heparin (Low Molecular Weight Heparin) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: Heparin (Ultra-Low Molecular Weight Heparin) Market: Sales Value (in Million US$), 2013 & 2018
Figure 19: Global: Heparin (Ultra-Low Molecular Weight Heparin) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: Global: Heparin (Bovine) Market: Sales Value (in Million US$), 2013 & 2018
Figure 21: Global: Heparin (Bovine) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Global: Heparin (Porcine) Market: Sales Value (in Million US$), 2013 & 2018
Figure 23: Global: Heparin (Porcine) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Global: Heparin (Oral) Market: Sales Value (in Million US$), 2013 & 2018
Figure 25: Global: Heparin (Oral) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Global: Heparin (Parenteral) Market: Sales Value (in Million US$), 2013 & 2018
Figure 27: Global: Heparin (Parenteral) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Global: Heparin (Atrial Fibrillation & Heart Attack) Market: Sales Value (in Million US$), 2013 & 2018
Figure 29: Global: Heparin (Atrial Fibrillation & Heart Attack) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 30: Global: Heparin (Stroke) Market: Sales Value (in Million US$), 2013 & 2018
Figure 31: Global: Heparin (Stroke) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 32: Global: Heparin (Deep Vein Thrombosis) Market: Sales Value (in Million US$), 2013 & 2018
Figure 33: Global: Heparin (Deep Vein Thrombosis) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 34: Global: Heparin (Pulmonary Embolism) Market: Sales Value (in Million US$), 2013 & 2018
Figure 35: Global: Heparin (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 36: Global: Heparin (Other Applications) Market: Sales Value (in Million US$), 2013 & 2018
Figure 37: Global: Heparin (Other Applications) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 38: Global: Heparin (Hospitals) Market: Sales Value (in Million US$), 2013 & 2018
Figure 39: Global: Heparin (Hospitals) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 40: Global: Heparin (Clinics) Market: Sales Value (in Million US$), 2013 & 2018
Figure 41: Global: Heparin (Clinics) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 42: Global: Heparin (Homecare Settings) Market: Sales Value (in Million US$), 2013 & 2018
Figure 43: Global: Heparin (Homecare Settings) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 44: Global: Heparin (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2013 & 2018
Figure 45: Global: Heparin (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 46: Global: Heparin (Other End-Users) Market: Sales Value (in Million US$), 2013 & 2018
Figure 47: Global: Heparin (Other End-Users) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 48: Global: Heparin Market: Sales through Hospital Pharmacies (in Million US$), 2013 & 2018
Figure 49: Global: Heparin Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2019-2024
Figure 50: Global: Heparin Market: Sales through Retail Pharmacies (in Million US$), 2013 & 2018
Figure 51: Global: Heparin Market Forecast: Sales through Retail Pharmacies (in Million US$), 2019-2024
Figure 52: Global: Heparin Market: Sales through Drug Stores (in Million US$), 2013 & 2018
Figure 53: Global: Heparin Market Forecast: Sales through Drug Stores (in Million US$), 2019-2024
Figure 54: Global: Heparin Market: Sales through Online Stores (in Million US$), 2013 & 2018
Figure 55: Global: Heparin Market Forecast: Sales through Online Stores (in Million US$), 2019-2024
Figure 56: Global: Heparin Market: Sales through Other Distribution Channels (in Million US$), 2013 & 2018
Figure 57: Global: Heparin Market Forecast: Sales through Other Distribution Channels (in Million US$), 2019-2024
Figure 58: Europe: Heparin Market: Sales Value (in Million US$), 2013 & 2018
Figure 59: Europe: Heparin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 60: North America: Heparin Market: Sales Value (in Million US$), 2013 & 2018
Figure 61: North America: Heparin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 62: Asia Pacific: Heparin Market: Sales Value (in Million US$), 2013 & 2018
Figure 63: Asia Pacific: Heparin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 64: Middle East and Africa: Heparin Market: Sales Value (in Million US$), 2013 & 2018
Figure 65: Middle East and Africa: Heparin Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 66: Latin America: Heparin Market: Sales Value (in Million US$), 2013 & 2018
Figure 67: Latin America: Heparin Market Forecast: Sales Value (in Million US$), 2019-2024


List of Tables

Table 1: Global: Heparin Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Heparin Market Forecast: Breakup by Product (in Million US$), 2019-2024
Table 3: Global: Heparin Market Forecast: Breakup by Source (in Million US$), 2019-2024
Table 4: Global: Heparin Market Forecast: Breakup by Mode of Administration (in Million US$), 2019-2024
Table 5: Global: Heparin Market Forecast: Breakup by Application (in Million US$), 2019-2024
Table 6: Global: Heparin Market Forecast: Breakup by End-User (in Million US$), 2019-2024
Table 7: Global: Heparin Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
Table 8: Global: Heparin Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 9: Global: Heparin Market Structure
Table 10: Global: Heparin Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links